EU

Advertisement
Nov 25 2025POLITICS

A Fresh Look at Macron's Take on Trump's Ukraine Peace Plan

Emmanuel Macron, the French President, shared his thoughts on Donald Trump's peace proposal for Ukraine. He acknowledged that the plan points in the right direction, but he believes it needs some tweaking. Macron emphasized that while peace is the goal, it shouldn't come at the cost of Ukraine's dig

reading time less than a minute
Nov 25 2025SPORTS

Tottenham's Midfield Mix-Up: Can a Change Spark a Turnaround?

Tottenham Hotspur is heading to Paris for a crucial match. After a tough loss to Arsenal, the team needs to bounce back. Fans are frustrated with the team's recent performances. The coach, Thomas Frank, might change things up. The team played a back five in the last game, but it didn't work. Now, t

reading time less than a minute
Nov 25 2025SCIENCE

A New Way to Build Important Molecules

Scientists have found a clever new way to make special molecules called α-CF3 allylamines. These molecules are super important in making medicines, pesticides, and other useful materials. The problem was that making them wasn't easy or efficient. The new method uses a special kind of chemistry call

reading time less than a minute
Nov 25 2025HEALTH

A Mission to Move Mountains: The Miami Project's Journey

The Miami Project to Cure Paralysis is more than just a research center; it's a beacon of hope for millions. It all started with a promise to Marc Buoniconti, who was left paralyzed after a football injury. His father, Nick Buoniconti, refused to accept that paralysis was untreatable. This determina

reading time less than a minute
Nov 25 2025FINANCE

Pfizer's Path to Growth: Is It Time to Buy?

Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp

reading time less than a minute
Nov 25 2025HEALTH

A Big Deal: Texas Takes on Pfizer Over ADHD Meds

Texas just made a big move against Pfizer. They settled a lawsuit for $41. 5 million. This was about a medicine called Quillivant XR. It's used to treat ADHD in kids. The issue? Tests showed the drug didn't work as it should. It didn't dissolve in the body. But the company kept saying it was fine.

reading time less than a minute
Nov 25 2025FINANCE

Pfizer's Move: Should You Reconsider BNTX Stock?

Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s

reading time less than a minute
Nov 25 2025BUSINESS

Big Pharma Hits a Trillion-Dollar Jackpot

Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.

reading time less than a minute
Nov 25 2025SCIENCE

How Exercise Shakes Up Your Brain Waves

Ever wonder why exercise makes you feel better? Scientists have been trying to figure out exactly how it changes our brains. A recent study took a close look at this by focusing on people who often feel anxious. They wanted to see if exercise could help them and how it might work in the brain. The

reading time less than a minute
Nov 24 2025FINANCE

Bitcoin's Rollercoaster Ride: When Belief Meets Reality

Bitcoin is currently trading at around $86, 000, but the real story is what's happening in the minds of investors. Experts are pointing out that the value of bitcoin is heavily influenced by what people believe it's worth. This is not a new idea, but it's becoming more important as the market faces

reading time less than a minute